Astrazeneca (AZN) Tax Rate (2009 - 2026)
Astrazeneca (AZN) posted quarterly Tax Rate of 10.06% for Q2 2026, down 903.0% year-over-year from 1.25% in Q2 2025, and up 147.25% quarter-over-quarter from 21.28% in Q1 2026.
Astrazeneca (AZN) Tax Rate (2009 - 2026) Analysis & Trends
Astrazeneca's Tax Rate history runs 18 years deep, the most recent figure standing at 10.06% for Q2 2026.
- In Q2 2026, Tax Rate fell 903.0% year-over-year to 10.06%; the TTM figure through Jun 2026 stood at 12.23% (down 876.0% YoY), while the FY2025 annual figure was 16.77%, down 222.0% from the prior year.
- Tax Rate for Q2 2026 stood at 10.06%, up from 21.28% in the prior quarter.
- The five-year high for Tax Rate was 78.09% in Q3 2022, with the low at 29.84% in Q1 2022.
- The 5-year median for Tax Rate is 15.36% (2023), against an average of 3.85%.
- The sharpest annual moves came in 2022 and 2023: Tax Rate jumped 9558 bps in 2022, then sank 9468 bps in 2023.
- Astrazeneca's Tax Rate stood at 15.94% in 2022, then plunged by 205 bps to 16.66% in 2023, then soared by 40 bps to 9.96% in 2024, then declined by 15 bps to 11.41% in 2025, then surged by 188 bps to 10.06% in 2026.
- Business Quant data shows AZN's Tax Rate at 10.06% in Q2 2026, 21.28% in Q1 2026, and 11.41% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 470.18 Bn | 463.61 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 376.85 Bn | 369.71 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn | 23.71% |
| 5 | Astrazeneca | 257.42 Bn | 252.52 Bn | 12.86 Bn | 10.40% |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 182.16 Bn | 178.98 Bn | 6.22 Bn | -2.36% |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn | 62.33% |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn | 56.21% |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -3.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.06% |
| Jun 30, 2026 | 10.06% |
| Jun 30, 2026 | 10.06% |
| Mar 31, 2026 | -21.28% |
| Mar 31, 2026 | -21.28% |
| Mar 31, 2026 | -21.28% |
| Dec 31, 2025 | -11.41% |
| Dec 31, 2025 | -11.41% |
| Dec 31, 2025 | -11.41% |
| Sep 30, 2025 | -21.86% |
| Sep 30, 2025 | -21.86% |
| Sep 30, 2025 | -21.86% |
| Jun 30, 2025 | 19.09% |
| Jun 30, 2025 | 19.09% |
| Jun 30, 2025 | 19.09% |
| Mar 31, 2025 | -14.14% |
| Mar 31, 2025 | -14.14% |
| Mar 31, 2025 | -14.14% |
| Dec 31, 2024 | -9.96% |
| Dec 31, 2024 | -9.96% |